EZH2 contributes to the response to PARP inhibitors through its PARP-mediated poly-ADP ribosylation in breast cancer
暂无分享,去创建一个
Jun Yao | G. Hortobagyi | L. Nie | M. Hung | Shih-Shin Chang | J. Hsu | H. Yamaguchi | Yongkun Wei | Wei‐Chao Chang | Chung-Hsuan Chen | H. Yamaguchi | S-S Chang | Yonghao Yu | Yi Du | J. Yao | K. Nakai | W.-C. Chang | Y. Du | M. Ding | Y. Wei | S. Jiao | C.-H. Chen | Y. Yu | Y. Du | L. Nie | Shiping Jiao | Katsuya Nakai | Ming Ding | Wei-Chao Chang